Global Self-Administered Drug Market Size, Share and Trends Analysis Report, By Type (Tablets, Syrups, Cream, and Injectables), By Indication (Pain Management, CVD, Osteoporosis, Diabetes, and Others), Forecast (2022-2028)

The global self-administered drugs market is anticipated to grow at a significant CAGR during the forecast period (2022- 2028). Self-administered medication is administered by patients themselves to control blood pressure, blood glucose, and other chronic illnesses. Active lifestyles have prompted patients to take medications which saves time and avoids going to hospitals. The growing incidences of chronic disorders such as diabetes and CVD are primarily contributing to the growth of the market. The market is segmented based on the type and indication. Based on the type, the market is sub-segmented into tablets, syrups, creams, and injectables. Injectables pharmaceuticals are drug product delivery systems that are used as an alternative to oral drugs and are more effective owing to rapid relief. Injectable pharmaceuticals are passed into the human body through syringes to the bloodstream and other parts of the body.

 

Some players in the market include Bristol-Myers Squibb Co., Abbott Laboratories, Gilead Sciences, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2021 Abbott Laboratories announced the acquisition of a medical device company, Walk Vascular LLC. This acquisition will expand the peripheral vascular offering of Abbott and will drive endovascular therapy solutions, thereby improving patient care. Further, in 2021, Pfizer Inc. announced to acquire Trillium Therapeutics Inc. Trillium Therapeutics which is a clinical-stage immune-oncology company that develops innovative therapies to treat cancer. Additionally, Novartis AG in 2020, acquired The Medicines Company. This acquisition will provide a unique opportunity to provide treatment to the world’s leading cause of disability and mortality with vaccines.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Indication
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Bristol-Myers Squibb Co., Abbott Laboratories, Gilead Sciences, Inc., among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Self-Administered Drug Market Report by Segment

By Product Type

• Tablets
• Syrups
• Creams
• Injectables

 

By Indication

• Pain Management
• CVD
• Osteoporosis
• Diabetes
• Others

 

Global Self-Administered Drug Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa